Sabra Health Care Reit, INC Form 4 insider transactions

NASDAQ
Sabra Health Care REIT Director Ann Kono acquired 887 common stock units through dividend equivalent payments, increasing her total beneficial ownership to 57,396 units.
NASDAQ
Sabra Health Care REIT Director Lynne S. Katzmann received 813 common stock units as dividend equivalents, increasing her beneficial ownership to 75,405 units.
NASDAQ
Sabra Health Care REIT Director Michael J. Foster reported a planned acquisition of 813 common stock units through dividend equivalent payments under a Rule 10b5-1(c) plan.
NASDAQ
Sabra Health Care REIT Director Catherine Cusack received 877 stock units as dividend equivalent payments, increasing her beneficial ownership to 71,276 shares.
NASDAQ
Sabra Health Care REIT, Inc. Director Craig A. Barbarosh was credited with 813 common stock units as dividend equivalent payments on existing awards.
NASDAQ
Sabra Health Care REIT's Executive VP & CAO, Jessica Flores, was credited with 367 stock units as dividend equivalent payments on existing awards.
NASDAQ
Sabra Health Care REIT's Executive VP, CIO & Treasurer, Talya Nevo-Hacohen, received 4,390 common stock units as dividend equivalent payments.
NASDAQ
Sabra Health Care REIT's Executive VP, CFO & Secretary, Michael Lourenco Costa, was credited with 3,473 stock units as dividend equivalent payments.
NASDAQ
Sabra Health Care REIT's CEO, Richard K. Matros, increased his beneficial ownership by 13,211 common stock units through dividend equivalent payments.
NASDAQ
Sabra Health Care REIT Director Michael J. Foster reported a pre-planned disposition of 750 common shares via gift, effective August 19, 2025.
NASDAQ
Sabra Health Care REIT, Inc. Director Michael J. Foster reported the acquisition of 750 shares of common stock through a grant, increasing his direct and indirect beneficial ownership.
NASDAQ
Sabra Health Care REIT, Inc. Director Jeffrey A. Malehorn was granted 8,178 restricted stock units, increasing his total beneficial ownership to 104,817 shares.
NASDAQ
Ann Kono, a Director at Sabra Health Care REIT, Inc., was granted 8,178 restricted stock units as part of her compensation, aligning her interests with shareholders.
NASDAQ
Sabra Health Care REIT, Inc. Director Lynne S. Katzmann was granted 8,178 restricted stock units, increasing her beneficial ownership to 74,592 shares.
NASDAQ
Sabra Health Care REIT, Inc. Director Michael J. Foster reported the acquisition of 8,178 restricted stock units as part of the company's 2009 Performance Incentive Plan.
NASDAQ
Sabra Health Care REIT, Inc. Director Catherine Cusack was granted 8,178 restricted stock units as part of her compensation, vesting over the next year.
NASDAQ
Sabra Health Care REIT, Inc. Director Craig A. Barbarosh was granted 8,178 restricted stock units, aligning his interests with shareholders.
NASDAQ
Sabra Health Care REIT, Inc. Director Clifton J Porter II acquired 827 common stock units through dividend equivalent payments, increasing his total beneficial ownership to 49,548 units.
NASDAQ
Jeffrey A. Malehorn, a Director at Sabra Health Care REIT, Inc., acquired 914 common stock units as dividend equivalent payments, increasing his total beneficial ownership to 96,639 shares.
NASDAQ
Sabra Health Care REIT, Inc. Director Ann Kono has reported an acquisition of 815 common stock units through dividend equivalent payments, increasing her total beneficial ownership to 48,331 units.
NASDAQ
Lynne S. Katzmann, a Director at Sabra Health Care REIT, Inc. (SBRA), acquired 914 common stock units through dividend equivalent payments, increasing her total beneficial ownership to 66,414 units.
NASDAQ
Michael J. Foster, a Director at Sabra Health Care REIT, Inc. (SBRA), has acquired 914 common stock units through dividend equivalent payments, increasing his direct beneficial ownership.
NASDAQ
Catherine Cusack, a Director at Sabra Health Care REIT, Inc., has been credited with 805 additional common stock units as dividend equivalent payments, increasing her total beneficial ownership to 62,221 units.
NASDAQ
Sabra Health Care REIT, Inc. Director Craig A. Barbarosh reported an acquisition of 914 common stock units through dividend equivalent payments, increasing his total beneficial ownership.
NASDAQ
Jessica Flores, Executive VP & CAO of Sabra Health Care REIT, Inc., was credited with 394 common stock units as dividend equivalent payments on May 30, 2025.
NASDAQ
Talya Nevo-Hacohen, Executive VP, CIO & Treasurer of Sabra Health Care REIT, Inc., was credited with 4,718 common stock units as dividend equivalent payments on existing equity awards.
NASDAQ
Sabra Health Care REIT's Executive VP, CFO & Secretary, Michael Lourenco Costa, has increased his beneficial ownership in the company by acquiring 3,736 common stock units through dividend equivalent payments.
NASDAQ
Sabra Health Care REIT's Chair, CEO, and President, Richard K. Matros, reported the acquisition of 14,197 common stock units through dividend equivalent payments, increasing his direct beneficial ownership to 841,437 units.
NASDAQ
Director Michael J. Foster sold 11,000 shares of Sabra Health Care REIT, Inc. common stock at a price of $18.216 per share on May 20, 2025.
NASDAQ
Director Clifton J. Porter II acquired 855 shares of Sabra Health Care REIT through dividend equivalent payments, increasing his total holdings to 48,721 shares.